Target Price | $90.33 |
Price | $56.98 |
Potential |
58.54%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Keros Therapeutics Inc 2025 .
The average Keros Therapeutics Inc target price is $90.33.
This is
58.54%
register free of charge
$105.00
84.28%
register free of charge
$76.00
33.38%
register free of charge
|
|
A rating was issued by 10 analysts: 10 Analysts recommend Keros Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Keros Therapeutics Inc stock has an average upside potential 2025 of
58.54%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.15 | 3.09 |
1,957.33% | ||
EBITDA Margin | -112,753.33% | -6,488.59% |
94.25% | ||
Net Margin | -125,389.33% | -5,806.13% |
95.37% |
10 Analysts have issued a sales forecast Keros Therapeutics Inc 2024 . The average Keros Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Keros Therapeutics Inc EBITDA forecast 2024. The average Keros Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Keros Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Keros Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.20 | -4.95 |
25.30% | 4.81% | |
P/E | negative | |
EV/Sales | 565.82 |
8 Analysts have issued a Keros Therapeutics Inc forecast for earnings per share. The average Keros Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Keros Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Keros Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.